Evotec AG, the Hamburg-based drug discovery and development company, has once again joined forces with scientists at Harvard University – this time to identify compounds that could prevent or slow down the loss of motor neurons in disease. ---Subscribe to MedNous to access this article--- Regenerative Medicine Company News Finance, Grants, Deals